Baseline characteristics of patients initiating mirabegron or antimuscarinics treatment for overactive bladder: Results from the PERSPECTIVE Registry

Rovner E1, Nair K2, Carlson K3, Oakkar E4, Park J4, Velentgas P4, Kristy R5, Gooch K5, Schermer C5

Research Type


Abstract Category

Overactive Bladder

Abstract 650
Open Discussion ePosters 3
Scientific Open Discussion ePoster Session 35
Friday 15th September 2017
13:35 - 13:40 (ePoster Station 7)
Exhibition Hall
Overactive Bladder Prospective Study Quality of Life (QoL) Incontinence Outcomes Research Methods
1. Medical University of South Carolina, 2. Center for Pharmaceutical Outcomes Research, Department of Clinical Pharmacy, University of Colorado, Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, 3. University of Calgary, 4. Quintiles IMS, 5. Astellas Pharma Global Development Inc

Eric Rovner